Information updates

MyEpiPen® Patient Support Program

Australia’s 35,000-member EpiClub® program has been revamped and rebranded by Viatris (formerly Mylan) as the MyEpiPen® Patient Support Program.

Benefits for patients who join MyEpiPen® include:

To access MyEpiPen® go to https://www.myepipen.com.au/

Patients in New Zealand are currently on a separate EpiClub® NZ site, and will transition to  MyEpiPen® in the near future.

ASCIA 2021 Virtual Conference registered delegates can attend the following Viatris sponsored sessions, as shown on page 10 of the ASCIA 2021 Conference Program Book https://ascia2021.com/program.php:

Thursday 2nd September, 9-9.45 AEST, ‘Risk Multipliers for Anaphylaxis’ presented by Prof Pete Smith.

Friday 3rd September 9-9.45 AEST, ‘Classic Hayfever, Local Allergic Rhinitis and Nasal Hyper-Reactivity: Sorting out Nasal Symptoms and Treatments’ presented by Prof Richard Harvey.

Register for the ASCIA 2021 Virtual Conference at https://ascia2021.com/registration.php